Acute Stroke Program of Interventions Addressing Racial and Ethnic Disparities "ASPIRE"


Phase N/A Results N/A

Summary of Purpose

The purpose of this study is to increase treatment of acute stroke with tissue plasminogen activator (tPA) across the District of Columbia. This study, however, will not evaluate tPA as an intervention.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 30 January 2014.

1 Feb 2008 28 Jul 2008 1 Jan 2013 1 Jan 2013 1 Jan 2014 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Observation: Ecologic or Community
  • Perspective: Prospective
  • Sampling: Non-Probability Sample


Not available